Vicarious Surgical (RBOT) Depreciation & Amortization (CF) (2020 - 2025)
Vicarious Surgical's (RBOT) quarterly Depreciation & Amortization (CF) came in at $352000.0 in Q3 2025, down 30.57% year-on-year from $507000.0 in Q3 2024, and down 14.77% on a QoQ basis from $413000.0 in Q2 2025.
Vicarious Surgical (RBOT) Depreciation & Amortization (CF) (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has 6 years of Depreciation & Amortization (CF) data on file, last reported at $352000.0 in Q3 2025.
- On a quarterly basis, Depreciation & Amortization (CF) fell 30.57% year-over-year to $352000.0 in Q3 2025; TTM through Dec 2025 was $1.1 million, a 45.85% decrease from a year earlier, with the FY2024 full-year figure at $2.1 million, up 13.65% from the prior year.
- Depreciation & Amortization (CF) for Q3 2025 stood at $352000.0, down from $413000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for RBOT reached as high as $542000.0 in Q4 2024 and fell as low as $41000.0 in Q1 2021.
- Historically, Depreciation & Amortization (CF) has averaged $342473.7 across 5 years, with a median of $402000.0 in 2022.
- Across the five-year window, Depreciation & Amortization (CF) soared 351.22% in 2022 and tumbled 30.57% in 2025, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $126000.0 in 2021, then soared by 219.05% to $402000.0 in 2022, then jumped by 30.6% to $525000.0 in 2023, then grew by 3.24% to $542000.0 in 2024, then sank by 35.06% to $352000.0 in 2025.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $352000.0 in Q3 2025, $413000.0 in Q2 2025, and $369000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vicarious Surgical | 654,984.55 | -9.14 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 352,000.00 |
| Sep 30, 2025 | 352,000.00 |
| Jun 30, 2025 | 413,000.00 |
| Jun 30, 2025 | 413,000.00 |
| Mar 31, 2025 | 369,000.00 |
| Mar 31, 2025 | 369,000.00 |
| Dec 31, 2024 | 542,000.00 |
| Dec 31, 2024 | 542,000.00 |
| Sep 30, 2024 | 507,000.00 |
| Sep 30, 2024 | 507,000.00 |
| Jun 30, 2024 | 524,000.00 |
| Jun 30, 2024 | 524,000.00 |
| Mar 31, 2024 | 521,000.00 |
| Mar 31, 2024 | 521,000.00 |
| Dec 31, 2023 | 525,000.00 |
| Dec 31, 2023 | 525,000.00 |
| Sep 30, 2023 | 447,000.00 |
| Sep 30, 2023 | 447,000.00 |
| Jun 30, 2023 | 440,000.00 |
| Jun 30, 2023 | 440,000.00 |